These results indicated that DR5 expression does not reflect the TRAIL sensitivity of the human pancreatic cancer cell lines and that other regulatory mechanisms determine their TRAIL sensitivity. The gene discussed is TNFRSF10B; the disease is familial pancreatic carcinoma.